CPRX Insider Trading Activity and SEC Form 4 Filings
Trump's trades in CPRX
From his financial disclosures
$45K+
3 purchases
$15K+
1 sale
Purchase
Apr 13, 2026
Reported 79d later
$15K - $50K
Purchase
Mar 4, 2026
Reported 71d later
$15K - $50K
Sale
Feb 26, 2026
Reported 77d later
$15K - $50K
Purchase
Jan 30, 2026
Reported 104d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
CPRX insider trading summary
Over the past 12 months, insiders at Catalyst Pharmaceuticals, Inc. (CPRX) reported 5 sales worth $1.8M by 3 insiders and no open-market purchases on SEC Form 4. Net insider selling was $1.8M.
Latest CPRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 12, 2025 | Molly Harper | Director | Sell | $106K (4,473 @ $23.73) |
| Dec 12, 2025 | Molly Harper | Director | Sell | $156K (6,746 @ $23.06) |
| Dec 12, 2025 | Molly Harper | Director | Sell | $360K (15,527 @ $23.20) |
| Nov 26, 2025 | Carmen Jeffrey Del | Chief Commercial Officer | Sell | $256K (10,983 @ $23.33) |
| Nov 12, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | Sell | $908K (40,000 @ $22.70) |
| Sep 8, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | Sell | $609K (30,000 @ $20.30) |
| Sep 4, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | Sell | $586K (30,000 @ $19.52) |
| Sep 3, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | Sell | $402K (20,000 @ $20.08) |
| Aug 27, 2025 | David S Tierney | Director | Sell | $525K (26,000 @ $20.20) |
| Aug 26, 2025 | Richard J Daly | President and CEO | Sell | $474K (22,970 @ $20.62) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.